Inspire Medical Systems (INSP) Invested Capital (2017 - 2022)

Inspire Medical Systems has disclosed Invested Capital across 6 years of filings, most recently posting $496.0 million for Q4 2022.

• In Q4 2022, Invested Capital rose 95.25% year-over-year to $496.0 million; the TTM figure through Dec 2022 stood at $496.0 million (up 95.25% YoY), while the FY2022 annual figure was $496.0 million, up 95.25% from the prior year.
• Invested Capital came in at $496.0 million for Q4 2022 at Inspire Medical Systems, up from $470.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $496.0 million in Q4 2022 to a low of $19.6 million in Q1 2018.
• Average Invested Capital over 5 years is $226.4 million, with a median of $245.0 million recorded in 2021.
• Year-over-year, Invested Capital soared 962.15% in 2018 and slipped 16.39% in 2020.
• Over 5 years, Invested Capital stood at $188.9 million in 2018, then retreated by 13.0% to $164.4 million in 2019, then soared by 54.84% to $254.5 million in 2020, then retreated by 0.18% to $254.0 million in 2021, then soared by 95.25% to $496.0 million in 2022.
• Per Business Quant data, the three most recent Invested Capital figures were $496.0 million in Q4 2022, $470.2 million in Q3 2022, and $249.0 million in Q2 2022.